North East Innovation Fund

Newcells Biotech Limited is a biotechnology company based in Newcastle upon Tyne, United Kingdom, specializing in the production of induced pluripotent stem cells (iPSCs) and their differentiation into various cell and tissue types. Founded in 2014, the company provides a selection of off-the-shelf iPSC-derived cell lines for research and development purposes. Their offerings include bespoke iPSCs derived from patient tissues, neural progenitor cells, cardiomyocytes for cardiac disease modeling, haematopoietic progenitor cells, and other somatic cell types tailored to user specifications. Additionally, Newcells Biotech supports drug discovery and pre-clinical development by developing in vitro cell-based assays that mimic the physiology of organs such as the kidney, retina, liver, and lung. This facilitates improved predictions of safety, pharmacology, and efficacy in drug testing, allowing researchers to evaluate new drug candidates effectively.

high expertise in the designing and testing of self-assembling peptides providing different benefits when culturing adherent cells in vitro.

Hicomply is a software platform that provides businesses with the tools necessary to develop and manage their information security management systems (ISMS) effectively. The platform offers a comprehensive solution for protecting business data and managing information security compliance. It features a customized interface that consolidates various aspects of information security management, allowing users to gain actionable insights. Hicomply includes a content-rich library of structured controls and risk information, which is aligned with relevant regulations, legislation, and industry standards. This enables organizations of all sizes to implement robust information security practices and enhance their overall data protection strategies.

Manus Neurodynamica Ltd manufactures medical diagnostic technologies for neuromotor impairments, including the non-invasive diagnosis and monitoring of Parkinson’s disease. Its technologies are used in academic research, pharmaceutical research, and non-medical applications. The company was founded in 2008 and is based in North Shields, United Kingdom.

BelleVie is a provider of personal care services focused on creating an environment where both caregivers and recipients can thrive. The company offers a range of support services, including personal care, meal preparation, home care, social engagement, and assistance with daily tasks. By facilitating these essential services, BelleVie enables individuals to receive the help they need while maintaining their independence and comfort in their own homes.

Incuto Limited is a financial technology company that specializes in developing SaaS banking software for credit unions, community banks, and community development financial institutions (CDFIs). Established in 2016 and based in Ilkley, United Kingdom, Incuto offers a comprehensive platform known as incuto Hive. This platform facilitates various back-office operations, enhances financial education, and improves communication and performance management for its clients. Incuto's technology allows credit unions to provide essential banking services, including debit cards and bank accounts, while enabling them to compete with high-cost lenders by offering accessible, rapid loans. The platform is designed to be user-friendly, accessible 24/7 across devices, and includes features such as automated income verification, mobile payments, and real-time fraud prevention. Through its innovative solutions, Incuto aims to empower credit unions and community banks to reduce operational costs and enhance their digital offerings.

Magnitude Biosciences Limited is a biotechnology company based in Durham, United Kingdom, that specializes in drug discovery solutions and services. Founded in 2018, the firm focuses on the ageing research sector by utilizing the nematode Caenorhabditis elegans in its studies. Magnitude Biosciences employs innovative technology, including small computers linked to cameras, to monitor these organisms under various conditions. This approach enables researchers to test a range of compounds, including food additives and pharmaceuticals, while generating high-quality, reproducible data. The company's services cater to both the global ageing research community and the broader drug discovery industry, addressing critical research areas such as neurodegeneration, toxicity, and microbiome studies. Magnitude Biosciences aims to enhance productivity and support the development of new therapeutic solutions.